Return To Sender, Industry Groups Say Of AER Address Guidance
This article was originally published in The Tan Sheet
Executive Summary
FDA's recommendation for complete addresses on OTC and dietary supplement product labels in order to comply with the adverse event reporting law exceeds not only Congress's intent, but also the requirements for all other products regulated by the agency, industry groups say
You may also be interested in...
Adverse Events Spark FDA Evaluation Of Topical Acne Ingredients
A recent uptick in the number of adverse events reported for benzoyl peroxide and salicylic acid products has pushed the regulatory agency to take a closer look at the potential for safety issues.
FDA Evaluates Topical Acne Ingredients After Adverse Event Report Jump
A recent uptick in the number of adverse events reported for benzoyl peroxide and salicylic acid products has pushed the regulatory agency to take a closer look at the potential for safety issues.
FDA Evaluates Topical Acne Ingredients After Adverse Event Report Jump
A recent uptick in the number of adverse events reported for benzoyl peroxide and salicylic acid products has pushed the regulatory agency to take a closer look at the potential for safety issues.